Cross-Adversarial Learning for Molecular Generation in Drug Design

• Published in: Frontiers in pharmacology Vol. 12; p. 827606
• Main Authors: Wu, Banghua, Li, Linjie, Cui, Yue, Zheng, Kai
• Format: Journal Article
• Language: English
• Published: Switzerland Frontiers Media S.A 21.01.2022
• Subjects: adversarial learning; adversarially regularized autoencoder; generative adversarial network; molecular generation; Pharmacology; projected gradient descent; generative adversarial network; projected gradient descent; molecular generation; adversarial learning; adversarially regularized autoencoder
• ISSN: 1663-9812; 1663-9812
• DOI: 10.3389/fphar.2021.827606

Molecular generation is an important but challenging task in drug design, as it requires optimization of chemical compound structures as well as many complex properties. Most of the existing methods use deep learning models to generate molecular representations. However, these methods are faced with the problems of generation validity and semantic information of labels. Considering these challenges, we propose a cross-adversarial learning method for molecular generation, CRAG for short, which integrates both the facticity of VAE-based methods and the diversity of GAN-based methods to further exploit the complex properties of Molecules. To be specific, an adversarially regularized encoder-decoder is used to transform molecules from simplified molecular input linear entry specification (SMILES) into discrete variables. Then, the discrete variables are trained to predict property and generate adversarial samples through projected gradient descent with corresponding labels. Our CRAG is trained using an adversarial pattern. Extensive experiments on two widely used benchmarks have demonstrated the effectiveness of our proposed method on a wide spectrum of metrics. We also utilize a novel metric named Novel/Sample to measure the overall generation effectiveness of models. Therefore, CRAG is promising for AI-based molecular design in various chemical applications.